Cymbiotika Debuts D3 K2 with CoQ10 Supplement for Cardiovascular Health

Emerging wellness brand introduces a plant-based formula to promote heart health

News provided by

Mar 05, 2020, 08:00 ET

LOS ANGELES, March 5, 2020 /PRNewswire/ -- Cymbiotika, a leading dietary supplement brand known for creating pure, clinically-backed supplements, announced today the release of the newest addition to its vegan and non-GMO product line, Synergy D3 K2 with CoQ10. Sourced and tested in the US, Cymbiotika's D3 K2 CoQ10 is the only 100% plant based formula of its kind made with zero synthetic ingredients.

There are hundreds of studies highlighting the powerful synergy between Vitamin D3 and Vitamin K2 and their ability to positively affect the cardiovascular system. D3 K2 CoQ10 doesn't stop there, it also supports bone growth and density, promotes a healthy mood, and increases mental clarity and productivity. "Our new Vegan D3 K2 CoQ10 Synergy formula is the center-point of what we stand for as an organization, and is the center-point of our health," said Cymbiotika Founder, Chervin Jafarieh. "This new formula covers a plethora of benefits and is scientifically proven for all sexes and age groups from pregnant women, children, the elderly, professional athletes and beyond. Today we are proud to offer the most comprehensive and absorbable D3 K2 CoQ10 formula ever created."

Cymbiotika's Vitashine™ D3 is the world's only Vegan and Vegetarian Society registered plant-source Vitamin D3 ingredient in the world. D3 is the most important epigenetic substance ever discovered, in charge of activating over 3,000 genes associated with healing. The formula's K2 is an organic blend of two of the most important forms of Vitamin K2; MK-4 & MK-7. Sourced from MenaQ7^® this MK-7 is the only clinically validated, patented, and bioavailable form of Vitamin K2 available on the market today. Additionally, the MK-4 is derived from fermented garbanzo beans, and is critical for pregnant women and their developing babies, with the ability to cross the placental barrier.

CoQ10 is arguably the most important antioxidant for the cardiovascular system and the addition of this ingredient in Ubiquinol form, trademarked by Kaneka™, helps to control the harmful effects of free radicals and oxidative stress directly related to the aging process. Kaneka Ubiquinol™ plays an essential role in cellular ATP (energy) production, while also providing defense against oxidative damage to the body's cells, including lipids, proteins and DNA. This patented version of CoQ10 has a much higher absorption rate than standard CoQ10 products.

Using a NANO bio-technology delivery system known as Micelle, Cymbiotika guarantees maximum absorption making these vital nutrients permeable on a subcellular level. Individual bottles are available at $77 (one-time purchase) or $67 (monthly, recurring subscription) and can be found on the brand's website.

About Cymbiotika

Founded in 2018, California based Cymbiotika is an innovative wellness brand, driven by a higher purpose, inspiring everyday people to reclaim control of their life by achieving optimal health. Cymbiotika is leading a nutritional revolution, backed by science, rooted in education and knowledge, inspiring the health of millions, while restoring the vitality of the planet and raising the current industry standards higher. Open sourcing only the highest quality plant-based nutrients, combined with the most advanced bioavailable absorption technology, the company never uses synthetics, GMOs, fillers, chemicals, preservatives, additives or sugars. Each supplement was created to resolve specific nutritional deficiencies and support healthy aging, detoxification and longevity. For more information, visit www.cymbiotika.com and on instagram @cymbiotika.

Contact: Eden Cali
The Co-Op Agency
[email protected]
310-734-7834

SOURCE Cymbiotika